Header

UZH-Logo

Maintenance Infos

European Society of Cardiology/European Atherosclerosis Society Task Force consensus statement on proprotein convertase subtilisin/kexin type 9 inhibitors: practical guidance for use in patients at very high cardiovascular risk


Landmesser, Ulf; John Chapman, M; Farnier, Michel; Gencer, Baris; Gielen, Stephan; Hovingh, G Kees; Lüscher, Thomas F; Sinning, David; Tokgözoğlu, Lale; Wiklund, Olov; Zamorano, Jose Luis; Pinto, Fausto J; Catapano, Alberico L; European Society of Cardiology (ESC); European Atherosclerosis Society (EAS) (2016). European Society of Cardiology/European Atherosclerosis Society Task Force consensus statement on proprotein convertase subtilisin/kexin type 9 inhibitors: practical guidance for use in patients at very high cardiovascular risk. European Heart Journal:ehw480.

Statistics

Altmetrics

Additional indexing

Item Type:Journal Article, refereed, further contribution
Communities & Collections:04 Faculty of Medicine > University Hospital Zurich > Clinic for Cardiology
Dewey Decimal Classification:610 Medicine & health
Language:English
Date:27 October 2016
Deposited On:10 Feb 2017 11:23
Last Modified:03 Jun 2017 12:23
Publisher:Oxford University Press
ISSN:0195-668X
Free access at:Publisher DOI. An embargo period may apply.
Publisher DOI:https://doi.org/10.1093/eurheartj/ehw480
PubMed ID:27789571

Download

Full text not available from this repository.
View at publisher

Author Collaborations